Rolland, Thomas https://orcid.org/0000-0001-6468-8391
Cliquet, Freddy https://orcid.org/0000-0002-9989-0685
Anney, Richard J. L. https://orcid.org/0000-0002-6083-407X
Moreau, Clara https://orcid.org/0000-0001-6217-731X
Traut, Nicolas
Mathieu, Alexandre
Huguet, Guillaume https://orcid.org/0000-0002-4746-6030
Duan, Jinjie
Warrier, Varun https://orcid.org/0000-0003-4532-8571
Portalier, Swan
Dry, Louise
Leblond, Claire S.
Douard, Elise https://orcid.org/0000-0003-4205-8828
Amsellem, Frédérique
Malesys, Simon https://orcid.org/0000-0003-1863-1970
Maruani, Anna
Toro, Roberto
Børglum, Anders D. https://orcid.org/0000-0001-8627-7219
Grove, Jakob https://orcid.org/0000-0003-2284-5744
Baron-Cohen, Simon https://orcid.org/0000-0001-9217-2544
Packer, Alan https://orcid.org/0000-0002-3171-8192
Chung, Wendy K. https://orcid.org/0000-0003-3438-5685
Jacquemont, Sébastien https://orcid.org/0000-0001-6838-8767
Delorme, Richard
Bourgeron, Thomas https://orcid.org/0000-0001-8164-9220
Funding for this research was provided by:
Simons Foundation (240059)
Innovative Medicines Initiative (777394)
Lundbeckfonden (R155-2014-1724, R248-2017-2003)
Institut Pasteur
Fondation Bettencourt Schueller
EC | Horizon 2020 Framework Programme (ANR-16-CONV-0005, 847818, 101057385)
Aarhus Universitet
Københavns Universitet
Wellcome Trust (214322\Z\18\Z)
Autism Speaks
European Federation of Pharmaceutical Industries and Associations
Autistica
Templeton World Charity Foundation
RCUK | MRC | Medical Research Foundation
DH | National Institute for Health Research
Université Paris Diderot
This work was funded by the Conny-Maeva Charitable Foundation, the Cognacq Jay Foundation, the Eranet-Neuron (ALTRUISM), and the GenMed Labex.
Article History
Received: 12 February 2021
Accepted: 19 May 2023
First Online: 26 June 2023
Competing interests
: The authors declare no competing interests.